Mirador Analytics

  • Home
  • Health Data Compliance Services
    • Health Data Compliance Overview
    • The Health Data Compliance Team
    • Health Data Compliance Services
  • Global Drug Development
    • Services Overview
    • The Global Drug Development Team
    • The View Platform
  • News & Insight
    • News
    • Insight Articles
  • Contact Us
  • Legal
    • Privacy Policy
    • Terms and Conditions
  • Home
  • Health Data Compliance Services
    • Health Data Compliance Overview
    • The Health Data Compliance Team
    • Health Data Compliance Services
  • Global Drug Development
    • Services Overview
    • The Global Drug Development Team
    • The View Platform
  • News & Insight
    • News
    • Insight Articles
  • Contact Us
  • Legal
    • Privacy Policy
    • Terms and Conditions

News

New Team Member

9/24/2018

0 Comments

 

Welcome to Kirsty MacRuary, Data Scientist

​We've got a new team member at Mirador Analytics!

It gives us great pleasure to welcome Kirsty to the data team here at Mirador Analytics! Kirsty will be working on our HIPAA Statistical Disclosure Risk Analyses and other Health Data Compliance projects with the Health Data Compliance Team.

Kirsty came to us from Sainsbury’s bank where she worked as a Modelling Analyst. Before this she worked at ISD (part of NHS NSS) as an analyst and statistician, after completing her PhD in Chemistry at the University of Edinburgh. 

It’s good to have you here Kirsty and we look forward to getting you involved in our projects!
0 Comments

New Appointment

5/29/2018

0 Comments

 

Welcome to Colin Moffatt, Data Scientist

We would like to take the time to welcome Colin Moffatt to the team. Colin joined us in April and is already making a great impact on our work within Health Data Compliance. Colin’s role as a data scientist will have him working on completing statistical risk analyses within our HIPAA statistical risk disclosure reports.   
Colin has 20 years’ experience in statistics and data analysis, having analysed the data for over 30 scientific publications and taught applied statistics to university students of all levels. He is a Fellow of the Royal Statistical Society with GradStat status and has an MSc in Data Science from Lancaster University. He has expertise in a variety of methods in statistical modelling, machine learning and data mining, being a long-time user of the software R.
Colin's background is in applied biology in which he holds a PhD from Imperial College London and an MRes from Lancaster University. He is a regular reviewer of submissions to several scientific journals and is an honorary lecturer at De Montfort University, Leicester.
Great to have you as part of the team Colin, looking forward to working together on lots more projects!
0 Comments

Health Data Compliance Services

3/7/2018

0 Comments

 

Mirador Analytics offering health data compliance service

We are delighted to introduce a recent service offering from the team at Mirador Analytics. We are now working with clients on Health Data Compliance projects, primarily focusing on health data compliance reports.

Organisations working with PHI (Private Health Information) data have to ensure patient privacy while maximising the value from their datasets in order to advance industry information. To work safely with their datasets organisations must ensure they are compliant.

Mirador saw that there was a backlog of health datasets which organisations were looking to assess before getting their data to work. We combined our pharma industry and data analytics knowledge with our network of data science specialists to offer statistical risk disclosure reports with a quick turnaround period.

More information can be found on the HIPAA Compliance Services page

Or email us at: info@miradoranalytics.com

*For other health data compliance services please get in touch
0 Comments

Insight Articles hub Launch

2/13/2018

0 Comments

 

New Article Insight Hub for Mirador Analytics

We have just launched a new hub on our website for our insight articles. Please check it out using the navigation bar in the top left of the Mirador Analytics Website. 
See our introduction to the new hub Here. 
0 Comments

Mirador Analytics, Data Talent Scotland Competition Winner

1/29/2018

0 Comments

 

Mirador Analytics announced as one of the winners of the DTS Startup Competition

We are delighted to announce that we were one of five winners of Data Talent Scotland's Startup Competition. 
​We will be attending the 2018 event in Glasgow this March. 

Now in its third year, Data Talent Scotland brings together aspiring data science and engineering students with employers from across the country. The event is an opportunity to network, discuss and learn from some of Scotland’s leading data leaders, professionals and researchers.

More info from Datafest HERE
Get in touch with us if you're going to be attending the event! 
#datafest18
Picture
0 Comments

Mirador Analytics Links with TGaS Advisors

9/18/2017

0 Comments

 

​TGaS Advisors Teams with UK’s Mirador Analytics to Bring a New Level of Forecasting to today’s Complex Biopharmaceutical Environment

From TGaS Advisors' Press Room
E. Norriton, Penn. and Melrose, UK. 9.14.17. Credible forecasts create hundreds of millions of dollars of additional value for biopharma companies and investors, according to research by TGaS Advisors, a benchmarking and advisory services firm for life sciences commercial operations. Understanding asset evaluation is considered a critical element of the drug commercialization process and a fundamental component underpinning global commercial strategy development. To enable life sciences companies to maximize both their asset development and strategic launch plans, TGaS has formed a partnership with Mirador Analytics, Ltd., a UK company with advanced global forecasting capabilities. The partnership makes  asset forecasting and benchmarking available as a holistic service offering to global biopharmaceutical organizations.

Read More
0 Comments

Paul Wheelhouse MSP Visit

6/23/2017

0 Comments

 

Paul Wheelhouse: Minister for Business , Innovation and Energy Visits Mirador


Read More
0 Comments

New Appointment: Chris Watson

5/31/2017

0 Comments

 

More Top Talent Joins Mirador

The Mirador team is pleased to announce the joining of Chris Watson to our team. Chris will join Mirador Analytics as Chief Development Officer.

See the full article for more information about Chris on LinkedIn by clicking HERE.

If you would like to get in touch with Chris or any other members of the team, please do so via the Contact Us page.
0 Comments

BioInformant Article: Asset Evaluation Tool

3/15/2017

 

Asset Evaluation Online Tool Launch Mention, BioInformant Research

The launch of our new online version of  the Asset Evaluation Tool has been shared via BioInformant Research.
BioInformant is the first and currently only market research firm specializing in the stem cell industry.

You can read the article on their website by clicking the link here: BioInformant: Asset Evaluation Tool Article

For further detail of the Asset Evaluation Online Tool, please use the "Contact Us" page or email directly via info@miradoranalytics.com

Asset Evaluation Tool: Online Version Launch

2/22/2017

 

​​Revolutionizing Asset Evaluation

Picture
We’re delighted to let you know that we’ve launched an online version of our prevalence-based Asset Evaluation Tool.

If you’re engaged in New Product Planning, Drug Development, Launch Planning, Portfolio Prioritization, Life Cycle Management or working towards a specific transaction (e.g. license and/or investment), I’d love to chat with you and explore how the Asset Evaluation Tool could support you through these processes. 

With online access via an annual license, unlimited remote asset forecasting is now available, providing you with greater forecasting freedom and flexibility. Mirador Analytics’ Asset Evaluation Tool is perfectly positioned to assist you with strategic decision making, optimizing value and assessing risk. Should you require assistance with inputs into the Asset Evaluation Tool, our experienced consulting team can support here. If required, we can also build a bespoke Forecasting Tool to match your company’s precise specifications.
Drug development and commercialization is an uncertain process. As a commercialization catalyst, Mirador Analytics helps foster the drug innovation process and provides drug commercialization assessment and launch planning services to biopharma SMEs around the world. With this in mind, alongside our Asset Evaluation services, we can also assist with Portfolio Prioritization, Life Cycle Management and Business Development Transactional Services.

Mirador Analytics is unique in comparison to other analytics and consulting organizations. We have extensive experience in the pharmaceutical sector and our team members have worked in similar senior-level roles to our clients. Alongside this, by combining both analytical and consultancy services we deliver relevant industry-specific outputs during every interaction with you.
​
To learn more about the Asset Evaluation Tool or to set up a complimentary trial, please get in touch via the contact us page.
Contact us
<<Previous

    Mirador Analytics

    Check out our news section for; our previous articles, events we are attending and other Mirador Analytics relevant updates. 

    GET IN TOUCH

    Archives

    September 2018
    May 2018
    March 2018
    February 2018
    January 2018
    September 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016

    Categories

    All
    Asset Valuation
    Benchmarking
    Compliance Services
    #datafest18
    DataTalentScotland
    Events
    Forecasting
    Health Data
    HIPAA
    Identification Services
    LCM Strategy And Portfolio Planning
    Partnerships
    Services
    Tools And Services

United Kingdom

Jamie Blackport, CEO
Tel: +44 (0)1896 802100
Picture
© 2019. Mirador Analytics Limited. All Rights Reserved.